Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHacettepe University
About this trial
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Eligibility criteria
Qualifiers
Aged 18 years or older
Having undergone a CT scan (at the L3 level) prior to treatment
No severe mental disorder and able to communicate effectively
Provided written informed consent
Disqualifiers
Did not provide written informed consent
Patients deemed unsuitable by the physician
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy06100, AnkaraAltındağ, Turkey (Türkiye)
Sponsors and collaborators
Hacettepe University
Lead sponsor
Source ClinicalTrials.gov